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a  b  s  t  r  a  c  t
The development of adequate mathematical models for blood glucose dynamics may
improve early diagnosis and control of diabetes mellitus (DM). We  have developed a stochas-
tic nonlinear second order differential equation to describe the response of blood glucose
concentration to food intake using continuous glucose monitoring (CGM) data. A variational
Bayesian learning scheme was applied to deﬁne the number and values of the system’s
parameters by iterative optimisation of free energy. The model has the minimal order and
number of parameters to successfully describe blood glucose dynamics in people with and
without DM. The model accounts for the nonlinearity and stochasticity of the underlying
glucose–insulin dynamic process. Being data-driven, it takes full advantage of available CGM
data  and, at the same time, reﬂects the intrinsic characteristics of the glucose–insulin sys-
tem without detailed knowledge of the physiological mechanisms. We  have shown that the
dynamics of some postprandial blood glucose excursions can be described by a reduced
(linear) model, previously seen in the literature. A comprehensive analysis demonstrates
that deterministic system parameters belong to different ranges for diabetes and controls.Implications for clinical practice are discussed. This is the ﬁrst study introducing a contin-
uous  data-driven nonlinear stochastic model capable of describing both DM and non-DM
proﬁles.
©  2015 The Authors. Published by Elsevier Ireland Ltd. This is an open access article under
tems dynamics. The latter includes four major properties:1.  Introduction
Tight glycaemic control using medication and life style
adjustments has proven effective in reducing or delaying com-
plications of DM [1]. There has also been major progress in the
development of model predictive control devices, i.e. artiﬁcial
pancreas systems [2] for type 1 diabetes (T1D), and attempts to
automatically control blood glucose variations in people with
type 2 diabetes (T2D) [3]. As stated in [2], the vital ingredient
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of predictive control algorithms is a model that captures
the relationship between glucose excursions, food intake
and insulin delivery. The development of such a model
represents a major challenge due to limited access to qual-
ity data, high cost of equipment for data collection, and,
most importantly, the complexity of the underlying sys-the glucose–insulin system is open, event-driven, nonlinear
and stochastic. These essential properties are rarely incor-
porated altogether into models of blood-glucose dynamics.
. This is an open access article under the CC BY license
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Fig. 1 – Example subcutaneous glucose time series G(t) of a
participant from the control group. The solid grey curves
represent the measured glucose values and the dots are the
values used for modelling of single postprandial peaks. The
solid and dashed vertical lines correspond to midnight (0 h)
and 6 am,  respectively. The ﬁrst several hours of data (to
the left from the ﬁrst solid vertical line) were  excluded fromc o m p u t e r m e t h o d s a n d p r o g r a m 
ne of the reasons is that the inherent system complexity
ften leads to over-complicated models with large numbers
f parameters, unsuitable for practical use. Let us brieﬂy
ummarise two main types of model available in the litera-
ure and highlight the advantages of the approach taken in
his work.
Phenomenological models [4–8] describe the underlying
hysiological process (production, distribution, and degrada-
ion of glucose and insulin) by compartments, each of which
s associated with several differential equations. Although the
nherent nonlinearity of the glucose–insulin interaction has
een recognised in these models, their application in predic-
ive control is limited by two factors: they are not person spe-
iﬁc and contain a high number of system parameters making
uch models hard to map  to low-dimensional data and to
alidate [9].
Data-driven models [5,10–13] are able to exploit the
nformation hidden in the data and predict glucose con-
entration without detailed knowledge of the underlying
hysiological processes [14]. An accepted challenge of such
ata-driven models is the interpretation of their parame-
ers. They also categorise every poor ﬁt as measurement
oise, without taking stochasticity in the data and uncer-
ainty in the model into consideration. In nonlinear systems,
oise acts as a driving force; it can radically modify
eterministic dynamics, and therefore clearly requires inclu-
ion in the model. This model uncertainty problem can
e addressed using probabilistic identiﬁcation techniques,
hich operate with parameter distributions rather than
ingle values, and such an approach is taken in this
ork.
The aim of this work was to ﬁnd a parsimonious model
ormulation, i.e. a model of minimal order and with a min-
mal number of parameters, for postprandial (after a single
ood intake) glucose dynamics. The model should account
or the essential systems properties listed above, and be suit-
ble to support the control strategies in clinical settings. The
ramework for our approach lies in the area of data-driven
onlinear stochastic differential equations modelling. Data-
riven models based on differential rather than difference
quations have been explored, e.g. in a single case study
15], and for linear systems [16]. It has been shown [15] that
ostprandial blood glucose excursions can be modelled by a
econd order linear differential equation in which food intake
s treated as a bolus injection of glucose, i.e. an impulsive force.
t has also been demonstrated [17] that such linear systems
an successfully describe some postprandial glucose excur-
ions in subjects without DM,  whereas a strong nonlinear
haracteristic of the responses was evident for many  DM pro-
les. This highlights the importance of including nonlinear
erms in modelling equations as opposed to linear systems
pproaches.
The structure of the article is as follows. Section 2 gives
etails on the data available for the analysis. Section 3 explains
he methodology for model formulation. Section 4 presents
he model, a detailed analysis of systems parameters for
roﬁles with and without DM,  and some clinically related
nterpretation. Section 5 summarises the results, justiﬁes the
eed for further work and outlines the relevance of the model
or DM management.modelling due to the adjustment period of the CGM system.
2.  Data  description
Datasets from 15 volunteers including ﬁve people without
DM (control group), four patients with T1D and six patients
with T2D was available for the study [17]. Recruitment was
purposive to ensure a diverse sample of ages and treatment
regimens. Baseline biographical data (Table A.1 in Appendix)
were obtained on age, sex, body mass index, type of diabetes,
treatment regimen and on recent HbA1c value, indicating the
average blood glucose level in the past 2–3 months. Subcuta-
neous glucose values (Fig. 1) were taken every 5 min  over 72 h
using the Medtronic Minimed CGM system [18]. No restrictions
were placed on usual daily activities of the participants.
The dotted peaks in the time series (Fig. 1) represent
the postprandial glucose concentration. To avoid mistaking
measurement error for genuine postprandial peaks, only dis-
tinguishable peaks with height more  than 1.1 mmol/L during
daytime from 6 am to midnight were selected. The highest
peak value for the participant in the control group is just below
8 mmol/L, whereas the highest values for the T1D and T2D
patients are greater than 15 mmol/L (not shown).
3.  Model  and  methods
3.1.  Model  formulation
There are three important characteristics of the blood glu-
cose response to food intake to be taken into account. Firstly,
the glucose response is nonlinear as explained in Section 1.
Secondly, stochasticity enters into the model in two  forms:
as measurement error (noise) arising from the device, and/or
as dynamical intrinsic noise resulting from factors other
than food intake, including physical activity and emotional
stress. For patients using insulin, inaccurate estimation of
the necessary dose is another factor inﬂuencing postprandial
excursions. Thirdly, the endocrine system tends to maintain
homoeostasis, and any deviations of blood glucose from the
basal level decay rapidly and return to the pre-disturbed state.
The basal glucose level usually demonstrates slow nonstation-
ary dynamics [17]. On the time scales corresponding to a single
peak, the variations are small compared with the changes of
m s i n b i o m e d i c i n e 1 2 5 ( 2 0 1 6 ) 18–25
Table 1 – Four model candidates for ﬁtting.
Models f1 f2
M1 k0 + k1xt + k2x2t 1xt + 2x2t + 3x3t
M2 k0 + k1xt + k2x2t 1xt20  c o m p u t e r m e t h o d s a n d p r o g r a 
baseline values from peak to peak, and therefore the glucose
basal level within one peak can be considered as constant.
Correspondingly, in our approach, basal level Gb is different
for each peak and is set individually according to the experi-
mental dataset. The glucose level over the baseline represents
the system’s transient response to food intake.
Glucose response to a single food intake in people with and
without DM can be considered as the following state-space
dynamical model:
d2
dt2
xt + f1(xt) ddt xt + f2(xt) = F
∫
ı(t)dt + t (1)
yt = xt + εt (2)
where
f1(xt) =
n∑
i=0
kix
i
t, f2(xt) =
m∑
j=1
jx
j
t (3)
Eq. (1) is the evolution (system’s) equation in which (xt,
dxt
dt )
is the state vector of the system [19], and t is the dynamic
noise. Output xt of the model (1) has the same meaning and
units as G(t); the two different notations are used to distinguish
between estimated and measured glucose time series. In the
measurement equation Eq. (2), yt is the output of the model in
the presence of measurement noise εt. Two stochastic terms,
the system noise t and the measurement noise εt, were mod-
elled as Gaussian-distributed white noise [20] with zero means
and intensities (variances) of Isys and Imeas, respectively. The
deterministic solution of the system (1)–(3), i.e. solution in the
absence of both noises, is denoted as xtd. In Eq. (1), F
∫
ı(t)dt
represents an external force (food intake), where F is regarded
as an unknown food impact factor, and ı(t) is the Dirac delta
function. The food intake therefore is considered as a bolus
injection of glucose at zero time moment [15].
Functions f1(xt) and f2(xt) play an important role in the sug-
gested model and introduce nonlinearity into the system. As
there was no preliminary information on the form of nonlin-
earity, the polynomial form of the functions was chosen due
to its generic nature and the ability to describe a wide variety
of solutions xt. A linear deterministic equation is a particular
case of this model when n = 0, m = 1, f1(xt) = k0 , f2(xt) = 1xt and
the stochastic terms are zero: t = 0, εt = 0. The linear noise-free
system has been considered in [15] and was based on one T2D
patient proﬁle.
3.2.  Optimal  model  selection,  inference  of  model
parameters  and  the  model’s  identiﬁability
The aim was to select the best model structure with the
minimal number of parameters for each postprandial peak.
To introduce sufﬁcient nonlinearity into the system without
overcomplicating the model, three polynomial terms were ini-
tially used in both functions f1 and f2. Note that using four or
more terms increases the probability of overﬁtting, rendering
the system unstable without improving parameter estimation.
While considering the three polynomial terms, some models
were disregarded; for example, it is known from the theoryM3 k0 1xt + 2x2t + 3x3t
ML k0 1xt
of dynamical systems that Eqs. (1)–(3) produce unstable solu-
tions for a range of initial conditions if the quadratic term is
kept but the cubic term is removed from function f2. Using this
reasoning, we  arrived at the four models presented in Table 1.
The ﬁrst model candidate M1  has full third order polynomial
functions f1 and f2. The second candidate M2 has three terms
in f1 and one linear term in f2. The third model M3 has three
terms in f2 and one term in f1. The three models have been
compared with each other and with the linear model (ML).
In order to decide which of the four models best describe
each postprandial event and, at the same time, identify corre-
sponding values of deterministic (ki , j) and stochastic (Isys,
Imeas) parameters, a variational Bayesian learning numeri-
cal algorithm was employed [21]. Speciﬁcally, the variational
Bayesian toolbox [21,22], initially developed for neuroimag-
ing data, was used with the corresponding modiﬁcations to
make it applicable to our CGM time series. The algorithm
accounts for the stochastic nature of the underlying glucose
dynamics and also enables us to distinguish the two types
of stochasticity: measurement and dynamic noise. This algo-
rithm is ﬂexible and delivers the model parameters in the
form of probabilistic distributions rather than ﬁxed values.
The ﬁnal result thereby includes information on uncertainties
in parameter estimates. As shown in [21], this approach out-
performs standard extended Kalman ﬁltering, the Bethe and
Kikuchi family of variational methods and is more  robust to
model misspeciﬁcation.
Mathematically, the value of probability p(yt|M), also
referred to as the model evidence, is found by numerically
integrating the product of the prior distributions (priors) of
the parameters p(ϑ|M) and the likelihood p(yt|ϑ, M) of observ-
ing time series yt given the parameters ϑ and the model M over
the distribution of all the parameters ϑ:
p(yt|M) =
∫
p(ϑ|M)p(yt|ϑ, M)dϑ (4)
In the Bayesian approach, the choice of priors has a par-
ticular importance since it inﬂuences the inferred (posterior)
parameter distributions. For deterministic parameters, nor-
mal  prior distributions were considered, which is a commonly
used form for an unknown variable. The mean values of the
priors for parameters k0 and 1 of linear terms were chosen in
accordance with [15], i.e. set to zero. Also, for consistency, in
models M1–M3, mean values of priors for remaining parame-
ters were set to zero. Since there was no prior knowledge about
the possible range of parameter values, large variances (104)
were set, i.e. priors with ﬂat distributions were considered
to allow the algorithm searching in a relatively wide region.
The large variances provide a weak informative prior, which
however converges with iterations towards a narrow ﬁnal (pos-
terior) distribution. The prior of the food impact factor F was
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Fig. 2 – Typical outcome for one peak ﬁtting by the four
models. Gb is the basal glucose level, G corresponds to the
measured glucose values (crosses) and xtd corresponds toc o m p u t e r m e t h o d s a n d p r o g r a m 
et to be normally distributed with a mean value of yt2 − yt1 ,
here yt1 and yt2 are the ﬁrst and second time points of each
eak, and variance of 104. The noise precisions, which are
nversely proportional to noise intensities and have to take
ositive values, were modelled by Gamma  distributions with
oth shape and rate parameters set to 0.001 [23].
In Eq. (4), letter ϑ represents the space of all parameters
n Eqs. (1)–(3). The integral in (4) is analytically intractable,
herefore the Laplace and the mean-ﬁeld approximations
ere used to calculate parameter probability distributions
(ϑ|M). The distribution of each parameter was approximated
y the ﬁrst two moments (mean and variance) known as
aplace approximation [24]. The combined distribution of all
he parameters was approximated by the product of individual
arameter distributions known as mean-ﬁeld approximation
24]. The estimated value of p(ϑ|M) is noted as q(ϑ), and makes
he integral Eq. (4) solvable. The estimated ﬁnal solution for
odel evidence p(yt|M)  is smaller than the true value due to
ecreased entropy [19]. The logarithm of p(yt|M)  is known as
free energy’ F(q(ϑ), yt) [19]. This value is maximised during the
rocess of optimising the model for our data and that, among
ther criteria, deﬁnes the goodness of ﬁt. The full procedure
or ﬁnding the parameters of the best model is referred to as
nference.
For each model candidate M (where M is M1, M2, M3 or ML),
he probability p(yt|M)  of observing the time series yt given
he model M,  was approached by iterative optimisation of the
odel parameters and the estimated states until a local maxi-
um value of p(yt|M)  was reached. The model with the highest
alue of p(yt|M)  was selected as the true model.
Note that in the linear case, the selected form of the model
uarantees structural identiﬁability. Indeed, as shown in [25]
f a linear stochastic model is stable, controllable and observ-
ble, its parameters are identiﬁable. For linear model ML, both
he controllability and observability matrices have full ranks,
nd we only consider stable solutions. For the nonlinear case,
he identiﬁability is diagnosed via the analysis of the variance
f parameters posterior distribution [26], and this is performed
utomatically in the framework of the variational Bayesian
pproach.
.3.  Data  ﬁtting
our models (ML, M1, M2  and M3) were compared to achieve
he most satisfactory ﬁtting. In order to select the best model,
he following two criteria were considered:
 The absolute value of the difference in free energy F
between any two models: |F|. According to [27], if |F| > 3,
there is strong evidence that the model with the higher
value of the free energy is better. This rule is derived from a
well known Bayes’ factor which is a measure for comparing
the evidences of two Bayesian models [27].
 The decay ratio. Since the glucose dynamics is tightly
regulated by the endocrine system, it is a stable process
with limited decaying oscillations except for patients in
critical conditions or T1D patients who have to maintain
the dynamics with insulin injections. Thus, any glucose
excursion after food intake should relax to a steady state
demonstrating the dynamics of an over-damped system. Inthe deterministic solutions of Eqs. (1)–(2).
the available time series the transient response correspond-
ing to one meal is often superimposed by that of another
meal, and consequently small oscillations might be hard to
observe. We  believe, however, that any model with a decay
ratio (ratio of the height of the second peak to the height of
the ﬁrst peak) higher than 0.33 is unrealistic, and should be
disregarded.
3.4.  Statistical  analysis
Statistical analysis of the models’ parameters was performed
using the Wilcoxon rank sum test. The null hypothesis of no
difference between the groups of interest was tested at the 5%
level of signiﬁcance, and this is presented by p-values.
4.  Results  and  discussion
4.1.  Optimal  model
Fig. 2 shows (typical) ﬁtting for one postprandial peak by the
four suggested models; only deterministic parts xtd of the solu-
tions are shown here and in the subsequent Figs. 3 and 5.
The most complex nonlinear model M1  produced an unstable
result with unrealistic periodic oscillations over time, which
was incompatible with the second criterion. Therefore, model
M1 was disregarded as unsatisfactory. The results also show
that M2, with reduction in the number of polynomial terms of
f2 to one, can successfully constrain the oscillations whereas
this is not the case for model M3. M3 was therefore also disre-
garded, leaving ML  and M2  for further consideration.
It is important to note that the linear model ML is a par-
ticular case of the nonlinear model M2 for k1 = 0 and k2 = 0.
The use of the two separate models was determined by the
feature of the stochastic inference algorithm, which was not
able to set the parameters k1 and k2 at zero value when M2
was applied to a peak with ‘linear’ transient dynamics. In this
situation the algorithm converged to a local, rather than the
global, maximum of free energy. We  were therefore forced to
consider two separate models.
Among 130 peaks across all ﬁfteen proﬁles, 84 peaks were
modelled (Table 2) by the linear ML  and 46 peaks were ﬁtted
22  c o m p u t e r m e t h o d s a n d p r o g r a m s i n b i o m e d i c i n e 1 2 5 ( 2 0 1 6 ) 18–25
Fig. 3 – The ﬁtting results are shown for: (a) a peak of a T2D
proﬁle; (b) a peak of a T1D proﬁle. Gb is the basal glucose
level, G corresponds to the measured glucose values
(crosses) and xtd corresponds to the deterministic solutions
of Eqs. (1)–(2).
Table 2 – Summary of peak ﬁtting using ML  and M2
Summary Total peaks Control T1D T2D
Total peaks 130 47 38 45
Fig. 4 – Boxplots for parameter
√
1 obtained from ML  (top
ﬁgure) and M2  (bottom ﬁgure).No. (%) ﬁtted by ML 84 36 (77%) 23 (61%) 25 (56%)
No. (%) ﬁtted by M2 46 11 (23%) 15 (39%) 20 (44%)
by the nonlinear M2. For the control group, ML worked for 77%
of the peaks; for the T1D and T2D group, only 61% and 56% of
the peaks could be described adequately by ML.
Some examples illustrating how the choice between mod-
els ML  and M2  was made are presented in Fig. 3. For Fig. 3a, the
free energy of ML  (FML = 24.0) is greater than the free energy
of M2  (FM2 = 20.8) producing |F| = |FML − FM2| = 3.2. The dif-
ference in free energies of the two models is slightly higher
than 3, and additionally the linear model does not satisfy the
second criterion: the decay ratio is 0.35. This means that the
oscillations are considered to be unrealistic, and therefore M2
was  chosen as the ﬁtting model. For the peak in Fig. 3b, abso-
lute free energy difference between ML and M2  is 72.6 and
free energy of M2  (FM2 = −1.1) is much higher than that of ML
(FML = −73.7), indicating a strong nonlinear character in this
peak. The linear model is not able to capture the dynamics of
this response, which is characterised by the existence of a sub-
peak. According to [28], the shape of a peak is dependent on
various factors including the macro-nutrients of food intake,
gender of the participants and time of food intake. Such dou-
ble (and multiple) peaks were commonly present in all the
proﬁles; however, subpeaks from T1D and T2D groups had a
larger inﬂuence over the parameter inference. In DM proﬁles
the peaks are generally higher and occur over a longer time
period compared with those from the control group, and as
such the effect of the sub-peak dynamics is more  distinctive
and increases the need for a nonlinear model to capture such
features.
Thus, 77% of peaks in the control group can be described
by a linear second order model whereas 23% are characterisedby nonlinear dynamics. There were more  nonlinear peaks in
DM groups than in controls: 39% in T1D and 44% in T2D,
which emphasises the nonlinear character of response in peo-
ple with DM. According to [29], the hyper- and hypo-glycaemic
regions show greater deviation from linear behaviour, explain-
ing the improved nonlinear ﬁtting for the T2D group.
With respect to stochastisity, the ﬁnal model for each peak
considered above contains both measurement and system
noise. However, before the ﬁnal model was selected as ﬁnal,
two separate models were investigated: one with measure-
ment noise only and another with both measurement and
system noise components. The stochastic model with both
noise was chosen as the ﬁnal model as it consistently out-
performed the measurement noise only model.
4.2.  Parameter  comparison  between  the  groups
The deterministic part of ML  is represented by two  parameters
k0 [1/min] and 1 [1/min
2], and of M2 by four parameters k0 ,
k1 [L/(mmol min)], k2 [L
2/(mmol2 min)] and 1.
4.2.1.  Coefﬁcients  of  function  f2 and  undamped  frequency
Functions f2 have the same structure for both linear and non-
linear models (Table 1), and contain coefﬁcient 1. The square
root of this parameter (
√
1) deﬁnes an undamped frequency,
at which a system would oscillate in the absence of any driving
or damping force. The values of
√
1 were compared among
the three groups (control, T1D and T2D) for models ML and
M2  (Fig. 4). If there was a signiﬁcant difference in medians
between any two groups, the p-values are marked by a star.
For the peaks that were ﬁtted by ML, the median value of
√
1
in the control group is signiﬁcantly higher than the median
values in DM groups, whereas there was no statistically signif-
icant difference between the two groups of T1D and T2D. Note
that the range of parameter values in the control group is also
much wider than in the DM groups. For the peaks ﬁtted by  M2,
the same result is observed:
√
1 differs signiﬁcantly between
diabetes and controls. Thus, by analysing the undamped
c o m p u t e r m e t h o d s a n d p r o g r a m s i n b i o m e d i c i n e 1 2 5 ( 2 0 1 6 ) 18–25 23
Table 3 – Summary of p-values for coefﬁcients of f1 in
M2.
Parameter Control-T1D Control-T2D T1D–T2D
k2 <0.001* 0.02* 0.17
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Fig. 5 – (a) Simulated time series from the maximal model,
xMM, for a non-DM case without any signs of DM (dotted
line), and (b) inferred time series xtdusing ML  (solid line).
Fig. 6 – Boxplots for (a) k0 and (b) 1 for all measured peaks
ﬁtted by ML  in our cohort of participants. Horizontal lines
mark MMk0 and 
MM
1 for no signs of DM (upper dashed green
line), low insulin sensitivity (middle solid line) and
impaired ˇ-cell function (lower dotted blue line) cases. (For
interpretation of the references to colour in this ﬁgure
legend, the reader is referred to the web version of thisk1 <0.001* 0.02* 0.18
k0 0.03* 0.02* 0.35
requency of the models developed it is possible to distinguish
etween the cases with and without DM.
.2.2.  Coefﬁcients  of  function  f1 and  damping
unctions f1 characterise damping in the systems and are rep-
esented by polynomials of different order for ML  and M2. The
onlinear model M2  contains a quadratic nonlinear ‘damping’
unction and is characterised by three parameters, whereas
he linear model ML  contains only one damping coefﬁcient.
hese inferred coefﬁcients have also been compared across
he three groups of controls and diabetes. For the linear damp-
ng parameter k0 of ML,  the p-values are as follows: p = 0 .03
*
control-T1D), p = 0 .01* (control-T2D) and p = 0.91 (T1D–T2D).
tatistical analysis for the nonlinear damping parameters of
2 is presented in Table 3. Thus, all three parameters k2 ,
k1 and k0 of M2  and parameter k0 of ML differ signiﬁcantly
etween diabetes and controls, and, therefore, can be used for
ifferentiating between the groups with and without DM.
It is important to notice that parameter k0 of the function
1 deﬁnes the system stability of both models, ML and M2. For
he system to be stable, the real parts of eigenvalues 1,2 of
he linear system ML or the linearised system M2  around the
teady state [x0, x˙0]
T must be negative:
1,2 = −
k0
2
± 1
2
√
2
k0
− 4k1 . (5)
ll the inferred parameters k0 were positive which conﬁrmed
he stability of the developed models.
.2.3.  Noise
arameters of the stochastic terms, i.e the intensities of the
ystem noise Isys [mmol2/(L2 min4)] and the measurement
oise Imeas [mmol2/L2] in ML and M2,  have also been compared
cross the three groups.
The intensities of the system noise were of the same order
cross all three groups for both models without any statisti-
ally signiﬁcant difference: p > 0.05. The source of the system
oise is the aggregate force accounting for other external fac-
ors such as physical activity, stress etc. which are not part of
he model (we have only considered the impact of food intake
n glucose dynamics). The inclusion of the system noise into
he analysis provides more  ﬂexibility in the model’s structure,
ut also accounts for its imperfection.
The measurement noise mainly comes from the inaccuracy
f the readings from the CGM devices. There were signiﬁcant
ifferences in Imeas values between the three groups for ML.
he higher intensities of measurement noise were observed
n T1D and T2D groups than in controls (p < 0.001 and p = 0.003
orrespondingly). This is well justiﬁed as the peak glucose lev-
ls are generally higher in DM than in the control group, and
he CGM devices are less accurate at the larger values. Forarticle.)
M2, there was no signiﬁcant difference in measurement noise
intensities across the three groups.
4.3.  Link  between  the  data-driven  model  and
physiological  models.  The  signs  of  pre-diabetes
A physiological maximal model (MM) [8] was used to generate
time series characterising three non-DM subjects: (i) without
any signs of DM, (ii) with low insulin sensitivity, and (iii) with
impaired ˇ-cell function. Cases (ii) and (iii) describe potential
T2D patients with partially impaired pancreatic function, and
are considered as pre-DM cases. The impaired function is com-
pensated by either secreting more  insulin or increasing tissue
sensitivity, and thus keeping the glucose levels still within the
healthy range.
These simulated time-series were used to infer parameters
of models (1)–(3) and to select the best model, exactly in the
same way as for the measured time-series. It was found that
the three cases can be ﬁtted by the linear model ML, and an
example result of ﬁtting for case (i) is shown in Fig. 5. Values of
the inferred parameter MM
k0
are as follows: (i) 0.027, (ii) 0.023,(iii) 0.021, and the values of MM1 are (i) 0.4, (ii) 0.25, (iii) 0.16.
They have been compared with k0 and 1 obtained for all mea-
sured peaks ﬁtted by ML  for our cohort of participants (Fig. 6).
m s i n24  c o m p u t e r m e t h o d s a n d p r o g r a 
It can be seen that the value of MM
k0
for the case without any
evidence of pre-DM locates in the interquartile range of the
boxplot for the control group (Fig. 6) and in the top quartile
for T2D. The values of MM
k0
for both pre-DM cases locate in the
lower part of the distribution for the control group, but within
the top part of the interquartile of the boxplot for T2D. A qual-
itatively similar result is observed for parameter MM
k1
(Fig. 6b):
the simulated value for case (i) without DM signs is within the
interquartile of the control group distribution and beyond the
interquartile of T2D. Similarly, pre-DM simulated values locate
within the bottom quartile of the control group and within
the interquartile of the T2D range. This clearly shows that
the two simulated cases fall into the area between the non-
DM and T2D distributions and can be interpreted as pre-DM
cases with impaired body functions. Therefore, a close obser-
vation of the trend of the parameters k0 and 1 might facilitate
early diagnosis of DM, particularly if such trends identify early
abnormalities in dynamics before mean glucose had risen sig-
niﬁcantly.
Note that together with the important physiological inter-
pretations, this section provides evidence of the robustness
of models (1)–(3) and their validation by comparison with
an established phenomenological model [8]. The solution of
(1)–(3) in Fig. 5b contains only 2 parameters and matches the
dynamics of the phenomenological maximal model [8] with
35 parameters (Fig. 5a). Being data-driven, models (1)–(3) take
full advantage of CGM data, and, at the same time, reﬂect the
intrinsic characteristics of the glucose–insulin system without
detailed knowledge of the underlying physiological mecha-
nisms.
Table A.1 – Biometric indices, treatment regimens, HbA1c value
levels of participants.
Proﬁle no. Age Sex BMI  Diabetes Treatme
(years) (kg/m2) status regimen
1 57 F 20.5 T1D basal bol
2 27 F 19.2 Control n/a 
3 59 F 27.3 Control n/a 
4 49 F 21.9 Control n/a 
5 32 F 29.4 T1D Insulin p
6 74 M 20.5 T2D Metform
7 66 F 25.9 T1D Insulin p
8 75 M 23.4 T2D Metform
9 68 F 32.7 T1D Basal bol
10 39 F 21.3 Control n/a 
11 61 F 32.6 T2D Metform
12 56 M 30.0 T2D Metform
13 52 F 44.5 T2D Metform
14 22 F 19.6 Control n/a 
15 63 F 27.0 T2D Newly di b i o m e d i c i n e 1 2 5 ( 2 0 1 6 ) 18–25
5.  Conclusions  and  limitations  of  the  study
A variational Bayesian method was successfully applied to
develop dynamical system equations for glucose time series
and to infer system parameters. The results demonstrate a
universal nonlinear stochastic model capable of capturing
the dynamics of postprandial glucose excursions in dia-
betes and controls. Deterministic parameters were found to
belong to different ranges for people with and without DM,
demonstrating the potential for useful clinical applications
including early diagnosis of DM,  studying the impact of var-
ious drugs on the stability of glucose responses as well as
control of DM.  The form of the model is compatible with phen-
omenological models which may allow useful physiological
parameter interpretations.
This study is limited by a relatively small sample of glu-
cose proﬁles. However, our results conﬁrm previous ﬁndings
[15] suggesting an ability to distinguish DM and non-DM
cases on the basis of system parameters, with promis-
ing interpretations for clinical use. The relationships that
we have uncovered between model parameters and clini-
cal phenotypes require further investigation to conﬁrm these
associations and elucidate the underlying mechanisms.
Due to the ethically sensitive nature of the research, no
interviewees consented to their data being retained or shared.
Additional details relating to other aspects of the data are
available from the University of Warwick institutional reposi-
tory: http://wrap.warwick.ac.uk/74860.Appendix  A.
s and corresponding estimated average blood glucose
nt HbA1c Glucose level
 (mmol/mol) (mmol/L)
us (glargine plus aspart) 63 10.0
n/a n/a
n/a n/a
n/a n/a
ump 55 9.0
in, gliclazide and rosiglitazone 61 9.7
ump 38 6.3
in 46 7.6
us (glargine plus aspart) 48 7.8
n/a n/a
in 52 8.4
in and gliclazide 68 10.8
in and glargine 89 13.8
n/a n/a
agnosed, diet only 42 7.0
s i n 
r
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